Results 1 to 10 of about 22,017 (188)
Journal of Prescribing Practice, 2022 In this column, Sharon Rees aims to refresh knowledge and interest in some of the commonly used drugs in a series of tweets. This month she is talking about #quetiapine
+6 more sources
Variants in COMT, CYP3A5, CYP2B6, and ABCG2 Alter Quetiapine Pharmacokinetics
Pharmaceutics, 2021 Quetiapine is an atypical antipsychotic widely used for the treatment of schizophrenia and the depressive episodes of bipolar disorder. The aim of this work was to investigate the effect of variants in relevant pharmacogenes in the pharmacokinetics of ...
Pablo Zubiaur +8 more
doaj +1 more source
Pharmacy, 2023 This systematic review compared the efficacy and tolerance of oral antipsychotics (APDs) used in the treatment of schizophrenia following the PRISMA-P© statement (n = 21).
Zina Sherzad Qadir +2 more
doaj +1 more source
Quetiapine-Induced Place Preference in Mice: Possible Dopaminergic Pathway
Pharmaceuticals, 2021 Quetiapine, an atypical antipsychotic, is effective in the management of schizophrenia, depression, and anxiety. Although quetiapine overdosage and misuse have been reported, its abuse potential has not been investigated in animals.
Yusuf S. Althobaiti
doaj +1 more source
Quantitative characterisation of extended-release tablets with quetiapine using NIR-chemometric methods [PDF]
Romanian Journal of Pharmaceutical Practice, 2021 This study aims to develop and validate NIR-chemometric methods for quantifying the API (quetiapine) and two excipients in extended-release tablets without sample preparation.
Teodora DRĂGAN +4 more
doaj +1 more source
Quetiapine for schizophrenia [PDF]
Cochrane Database of Systematic Reviews, 2004 Quetiapine is an atypical antipsychotic with, theoretically, a low propensity for movement disorder adverse effects. It is used for the treatment of schizophrenia and other psychoses.To determine the effects of quetiapine for schizophrenia in comparison to placebo, and other antipsychotics.Electronic searches of the Cochrane Schizophrenia Group's ...
Manit Srisurapanont +4 more
openaire +2 more sources
Post‐therapy plasma concentrations of quetiapine in Taiwanese patients
Neuropsychopharmacology Reports, 2023 Aims Quetiapine is widely used to treat psychiatric disorders such as major depression, generalized anxiety disorder, dysthymic disorder, and insomnia other than schizophrenia and bipolar disorder.
Cho‐Yin Huang +3 more
doaj +1 more source
BMC Psychiatry, 2005 Background Although serotonin reuptake inhibitors are effective in the treatment of OCD, many patients fail to respond to these agents. Growing evidence from open-label and placebo-controlled trials suggests a role for augmentation of SRIs with atypical ...
van Ameringen Michael +5 more
doaj +1 more source
Archives of Academic Emergency Medicine, 2018 Introduction: About 5% of visits to emergency departments are made up of conversion disorder cases. This study was designed with the aim of comparing the effectiveness of quetiapine and haloperidol in controlling conversion disorder symptoms.
Saeed Reza Ghanbarizadeh +6 more
doaj +1 more source
Effect of a dosing-time on quetiapine-induced acute hyperglycemia in mice
Journal of Pharmacological Sciences, 2017 Although rare, second-generation antipsychotic drugs cause severe hyperglycemia within several days after the initiation of therapy. Because glucose tolerance exhibits circadian rhythmicity, we evaluated an effect of a dosing-time on quetiapine-induced ...
Snehal Kapse +9 more
doaj +1 more source